Ann-Marie Malby Schoos

Dr. Ann-Marie Malby Schoos

COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Ledreborg Alle 34, 2820 Gentofte, Denmark
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
JSJakob Stokholm
Jakob Stokholm
MBMartin Blaser
Martin Blaser
JTJonathan Thorsen
Jonathan Thorsen
MRMorten Arendt Rasmussen
Morten Arendt Rasmussen
JWJohannes Waage
Johannes Waage
HBHans Bisgaard
Hans Bisgaard
The composition of the human gut microbiome matures within the first years of life. It has been hypothesized that microbial compositions in this period can cause immune dysregulations and potentially cause asthma. Here we show, by associating gut microbial composition from 16S rRNA gene amplicon sequencing during the first year of life with subsequent risk of asthma in 690 participants, that 1-year-old children with an immature microbial composition have an increased risk of asthma at age 5 years. This association is only apparent among children born to asthmatic mothers, suggesting that lacking microbial stimulation during the first year of life can trigger their inherited asthma risk. Conversely, adequate maturation of the gut microbiome in this period may protect these pre-disposed children.

29 December 2016 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
HBHans Bisgaard
Hans Bisgaard
JSJakob Stokholm
Jakob Stokholm
Bo ChawesBo Chawes
Bo Chawes
NVNadja H. Vissing
Nadja H. Vissing
EBElin Bjarnadóttir
Elin Bjarnadóttir
KBKlaus Bønnelykke
Klaus Bønnelykke
Reduced intake of n−3 long-chain polyunsaturated fatty acids (LCPUFAs) may be a contributing factor to the increasing prevalence of wheezing disorders. We assessed the effect of supplementation with n−3 LCPUFAs in pregnant women on the risk of persistent wheeze and asthma in their offspring.

26 January 2016 in JAMA
Verified
Journal Article
Closed access
PDF file
Bo ChawesBo Chawes
Bo Chawes
KBKlaus Bønnelykke
Klaus Bønnelykke
JSJakob Stokholm
Jakob Stokholm
NVNadja H. Vissing
Nadja H. Vissing
EBElín Bjarnadóttir
Elín Bjarnadóttir
HBHans Bisgaard
Hans Bisgaard
Research from JAMA — Effect of Vitamin D3 Supplementation During Pregnancy on Risk of Persistent Wheeze in the Offspring — A Randomized Clinical Trial

1 January 2016 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
JSJakob Stokholm
Jakob Stokholm
Bo ChawesBo Chawes
Bo Chawes
NVNadja H Vissing
Nadja H Vissing
EBElín Bjarnadóttir
Elín Bjarnadóttir
TPTine M Pedersen
Tine M Pedersen
HBHans Bisgaard
Hans Bisgaard

4 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ABAshley Budu-Aggrey
Ashley Budu-Aggrey
AKAnna Kilanowski
Anna Kilanowski
MSMaria Kinga Sobczyk
Maria Kinga Sobczyk
SSSuyash S. Shringarpure
Suyash S. Shringarpure
RMRuth Mitchell
Ruth Mitchell
LPLavinia Paternoster
Lavinia Paternoster
Atopic dermatitis (AD) is a common inflammatory skin condition and prior genome-wide association studies (GWAS) have identified 71 associated loci. In the current study we conducted the largest AD GWAS to date (discovery N = 1,086,394, replication N = 3,604,027), combining previously reported cohorts with additional available data. We identified 81 loci (29 novel) in the European-only analysis (which all replicated in a separate European analysis) and 10 additional loci in the multi-ancestry analysis (3 novel). Eight variants from the multi-ancestry analysis replicated in at least one of the populations tested (European, Latino or African), while two may be specific to individuals of Japanese ancestry. AD loci showed enrichment for DNAse I hypersensitivity and eQTL associations in blood. At each locus we prioritised candidate genes by integrating multi-omic data. The implicated genes are predominantly in immune pathways of relevance to atopic inflammation and some offer drug repurposing opportunities.

12 June 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Bo ChawesBo Chawes
Bo Chawes
KBKlaus Bønnelykke
Klaus Bønnelykke
PJPia F. Jensen
Pia F. Jensen
Ann-Marie Malby SchoosAnn-Marie Malby Schoos
Ann-Marie Malby Schoos
LHLene Heickendorff
Lene Heickendorff
HBHans Bisgaard
Hans Bisgaard
Epidemiological studies have suggested an association between maternal vitamin D dietary intake during pregnancy and risk of asthma and allergy in the offspring. However, prospective clinical studies on vitamin D measured in cord blood and development of clinical end-points are sparse. To investigate the interdependence of cord blood 25-hydroxyvitamin D (25(OH)-Vitamin D) level and investigator-diagnosed asthma- and allergy-related conditions during preschool-age. Cord blood 25(OH)-Vitamin D level was measured in 257 children from the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC2000) at-risk mother-child cohort. Troublesome lung symptoms (TROLS), asthma, respiratory infections, allergic rhinitis, and eczema, at age 0–7 yrs were diagnosed exclusively by the COPSAC pediatricians strictly adhering to predefined algorithms. Objective assessments of lung function and sensitization were performed repeatedly from birth. After adjusting for season of birth, deficient cord blood 25(OH)-Vitamin D level (<50 nmol/L) was associated with a 2.7-fold increased risk of recurrent TROLS (HR = 2.65; 95% CI = 1.02–6.86), but showed no association with respiratory infections or asthma. We saw no association between cord blood 25(OH)-Vitamin D level and lung function, sensitization, rhinitis or eczema. The effects were unaffected from adjusting for multiple lifestyle factors. Cord blood 25(OH)-Vitamin D deficiency associated with increased risk of recurrent TROLS till age 7 years. Randomized controlled trials of vitamin D supplementation during pregnancy are needed to prove causality.